Elon Musk has issued a series of bold and forward-looking statements in response to Tesla shareholders' recent endorsement of his staggering trillion-dollar compensation package. He offered intriguing insights into the company's potential trajectory in the years ahead.

Musk confidently predicted that Tesla's humanoid robots would initially take on straightforward tasks and, over time, evolve to perform surgeries with a level of precision that far exceeds human capabilities. This vision paints a picture of a future where advanced robotics play a pivotal role in medical procedures.

Furthermore, Musk disclosed that Tesla's humanoid robots are slated to commence mass production next year. The inaugural production line, set to be established at the Fremont factory, will boast an impressive annual capacity of 1 million units. Subsequently, the Texas factory will ramp up its annual production capacity to a staggering 10 million units, marking a significant expansion in Tesla's manufacturing capabilities.

Once production reaches the 1 million unit milestone annually, Musk anticipates that production costs will plummet to around $20,000 per unit. This cost reduction could potentially make Tesla's humanoid robots more accessible and competitive in the market.

In addition to these robotics-related revelations, Musk also delved into Tesla's ongoing advancements in autonomous driving technology, chip development, and other key areas of innovation. His remarks underscored Tesla's commitment to pushing the boundaries of what is possible in the automotive and technology sectors.